ACI Global Corporation
ACI Global Corporation ACGJ Peers
See (ACGJ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACGJ | $0.00 | -100.00% | 324 | -0.00 | -$0.07 | N/A |
| CLCGY | $43.44 | -1.81% | 20.6B | 30.81 | $1.41 | +0.08% |
| ALBHF | $0.60 | N/A | 9.6B | 60.00 | $0.01 | N/A |
| ALBBY | $10.16 | -6.37% | 8.2B | 40.65 | $0.25 | N/A |
| MSMKF | $19.70 | +8.84% | 8B | 21.18 | $0.93 | +1.53% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| GEDSF | $25.95 | +4.43% | 4.7B | 11.19 | $2.32 | +4.50% |
| RADLY | $2.74 | +0.16% | 4.7B | 21.11 | $0.13 | +0.40% |
| WLCGF | $21.50 | +31.02% | 4.5B | 25.60 | $0.84 | +0.58% |
| CSMYF | $46.06 | -0.22% | 3.7B | 19.77 | $2.33 | +0.89% |
Stock Comparison
ACGJ vs CLCGY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, CLCGY has a market cap of 20.6B. Regarding current trading prices, ACGJ is priced at $0.00, while CLCGY trades at $43.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas CLCGY's P/E ratio is 30.81. In terms of profitability, ACGJ's ROE is N/A, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, ACGJ is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs ALBHF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ALBHF has a market cap of 9.6B. Regarding current trading prices, ACGJ is priced at $0.00, while ALBHF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ALBHF's P/E ratio is 60.00. In terms of profitability, ACGJ's ROE is N/A, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, ACGJ and ALBHF have similar daily volatility (0.00).
ACGJ vs ALBBY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ALBBY has a market cap of 8.2B. Regarding current trading prices, ACGJ is priced at $0.00, while ALBBY trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ALBBY's P/E ratio is 40.65. In terms of profitability, ACGJ's ROE is N/A, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, ACGJ and ALBBY have similar daily volatility (0.00).
ACGJ vs MSMKF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, MSMKF has a market cap of 8B. Regarding current trading prices, ACGJ is priced at $0.00, while MSMKF trades at $19.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas MSMKF's P/E ratio is 21.18. In terms of profitability, ACGJ's ROE is N/A, compared to MSMKF's ROE of +0.07%. Regarding short-term risk, ACGJ and MSMKF have similar daily volatility (0.00).
ACGJ vs DCHPF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, ACGJ is priced at $0.00, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, ACGJ's ROE is N/A, compared to DCHPF's ROE of N/A. Regarding short-term risk, ACGJ and DCHPF have similar daily volatility (0.00).
ACGJ vs GEDSF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, GEDSF has a market cap of 4.7B. Regarding current trading prices, ACGJ is priced at $0.00, while GEDSF trades at $25.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas GEDSF's P/E ratio is 11.19. In terms of profitability, ACGJ's ROE is N/A, compared to GEDSF's ROE of +0.15%. Regarding short-term risk, ACGJ is less volatile compared to GEDSF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs RADLY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, RADLY has a market cap of 4.7B. Regarding current trading prices, ACGJ is priced at $0.00, while RADLY trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas RADLY's P/E ratio is 21.11. In terms of profitability, ACGJ's ROE is N/A, compared to RADLY's ROE of +0.18%. Regarding short-term risk, ACGJ is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs WLCGF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, WLCGF has a market cap of 4.5B. Regarding current trading prices, ACGJ is priced at $0.00, while WLCGF trades at $21.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas WLCGF's P/E ratio is 25.60. In terms of profitability, ACGJ's ROE is N/A, compared to WLCGF's ROE of +0.09%. Regarding short-term risk, ACGJ is less volatile compared to WLCGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs CSMYF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, CSMYF has a market cap of 3.7B. Regarding current trading prices, ACGJ is priced at $0.00, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, ACGJ's ROE is N/A, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, ACGJ is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs SDGCF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SDGCF has a market cap of 3.6B. Regarding current trading prices, ACGJ is priced at $0.00, while SDGCF trades at $30.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SDGCF's P/E ratio is 19.12. In terms of profitability, ACGJ's ROE is N/A, compared to SDGCF's ROE of +0.05%. Regarding short-term risk, ACGJ is less volatile compared to SDGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs RGEDF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, RGEDF has a market cap of 3.1B. Regarding current trading prices, ACGJ is priced at $0.00, while RGEDF trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas RGEDF's P/E ratio is 5.00. In terms of profitability, ACGJ's ROE is N/A, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, ACGJ is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs TSUSF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, TSUSF has a market cap of 3B. Regarding current trading prices, ACGJ is priced at $0.00, while TSUSF trades at $60.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas TSUSF's P/E ratio is 18.62. In terms of profitability, ACGJ's ROE is N/A, compared to TSUSF's ROE of +0.09%. Regarding short-term risk, ACGJ and TSUSF have similar daily volatility (0.00).
ACGJ vs SGIPF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, ACGJ is priced at $0.00, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, ACGJ's ROE is N/A, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, ACGJ and SGIPF have similar daily volatility (0.00).
ACGJ vs SAEYY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SAEYY has a market cap of 2.8B. Regarding current trading prices, ACGJ is priced at $0.00, while SAEYY trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SAEYY's P/E ratio is -51.15. In terms of profitability, ACGJ's ROE is N/A, compared to SAEYY's ROE of -0.09%. Regarding short-term risk, ACGJ and SAEYY have similar daily volatility (0.00).
ACGJ vs SHPPF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SHPPF has a market cap of 2.8B. Regarding current trading prices, ACGJ is priced at $0.00, while SHPPF trades at $135.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SHPPF's P/E ratio is -49.56. In terms of profitability, ACGJ's ROE is N/A, compared to SHPPF's ROE of -0.09%. Regarding short-term risk, ACGJ is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs HTSUY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, HTSUY has a market cap of 2.3B. Regarding current trading prices, ACGJ is priced at $0.00, while HTSUY trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas HTSUY's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, ACGJ is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs ZRSEF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ZRSEF has a market cap of 1.4B. Regarding current trading prices, ACGJ is priced at $0.00, while ZRSEF trades at $36.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ZRSEF's P/E ratio is -7.35. In terms of profitability, ACGJ's ROE is N/A, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, ACGJ and ZRSEF have similar daily volatility (0.00).
ACGJ vs FOGCF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, FOGCF has a market cap of 660.8M. Regarding current trading prices, ACGJ is priced at $0.00, while FOGCF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas FOGCF's P/E ratio is -0.38. In terms of profitability, ACGJ's ROE is N/A, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, ACGJ is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs BJTRF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, BJTRF has a market cap of 535.9M. Regarding current trading prices, ACGJ is priced at $0.00, while BJTRF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas BJTRF's P/E ratio is 8.00. In terms of profitability, ACGJ's ROE is N/A, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, ACGJ and BJTRF have similar daily volatility (0.00).
ACGJ vs NVACF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, ACGJ is priced at $0.00, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas NVACF's P/E ratio is 31.60. In terms of profitability, ACGJ's ROE is N/A, compared to NVACF's ROE of +0.06%. Regarding short-term risk, ACGJ is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs KIARF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, KIARF has a market cap of 67.2M. Regarding current trading prices, ACGJ is priced at $0.00, while KIARF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas KIARF's P/E ratio is -0.01. In terms of profitability, ACGJ's ROE is N/A, compared to KIARF's ROE of -1.47%. Regarding short-term risk, ACGJ and KIARF have similar daily volatility (0.00).
ACGJ vs HTPRF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, HTPRF has a market cap of 12M. Regarding current trading prices, ACGJ is priced at $0.00, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, ACGJ's ROE is N/A, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, ACGJ and HTPRF have similar daily volatility (0.00).
ACGJ vs ETBI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ETBI has a market cap of 9M. Regarding current trading prices, ACGJ is priced at $0.00, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ETBI's P/E ratio is -0.40. In terms of profitability, ACGJ's ROE is N/A, compared to ETBI's ROE of +0.00%. Regarding short-term risk, ACGJ and ETBI have similar daily volatility (0.00).
ACGJ vs PNPL Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, PNPL has a market cap of 7.3M. Regarding current trading prices, ACGJ is priced at $0.00, while PNPL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas PNPL's P/E ratio is -10.00. In terms of profitability, ACGJ's ROE is N/A, compared to PNPL's ROE of +0.54%. Regarding short-term risk, ACGJ and PNPL have similar daily volatility (0.00).
ACGJ vs WPHM Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, WPHM has a market cap of 7M. Regarding current trading prices, ACGJ is priced at $0.00, while WPHM trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas WPHM's P/E ratio is -2.57. In terms of profitability, ACGJ's ROE is N/A, compared to WPHM's ROE of -1.56%. Regarding short-term risk, ACGJ is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs FFLWF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, ACGJ is priced at $0.00, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, ACGJ's ROE is N/A, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, ACGJ is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs RLLVF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, RLLVF has a market cap of 5.3M. Regarding current trading prices, ACGJ is priced at $0.00, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, ACGJ's ROE is N/A, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, ACGJ and RLLVF have similar daily volatility (0.00).
ACGJ vs HEWA Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, HEWA has a market cap of 4.2M. Regarding current trading prices, ACGJ is priced at $0.00, while HEWA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas HEWA's P/E ratio is -3.27. In terms of profitability, ACGJ's ROE is N/A, compared to HEWA's ROE of +0.08%. Regarding short-term risk, ACGJ and HEWA have similar daily volatility (0.00).
ACGJ vs SYDRF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SYDRF has a market cap of 2.9M. Regarding current trading prices, ACGJ is priced at $0.00, while SYDRF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SYDRF's P/E ratio is 10.00. In terms of profitability, ACGJ's ROE is N/A, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, ACGJ and SYDRF have similar daily volatility (0.00).
ACGJ vs LGNZZ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, LGNZZ has a market cap of 2.7M. Regarding current trading prices, ACGJ is priced at $0.00, while LGNZZ trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, ACGJ and LGNZZ have similar daily volatility (0.00).
ACGJ vs GABLF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, ACGJ is priced at $0.00, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas GABLF's P/E ratio is -0.04. In terms of profitability, ACGJ's ROE is N/A, compared to GABLF's ROE of +2.91%. Regarding short-term risk, ACGJ and GABLF have similar daily volatility (0.00).
ACGJ vs IWINF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, ACGJ is priced at $0.00, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas IWINF's P/E ratio is -0.06. In terms of profitability, ACGJ's ROE is N/A, compared to IWINF's ROE of -0.21%. Regarding short-term risk, ACGJ and IWINF have similar daily volatility (0.00).
ACGJ vs NUTTQ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, ACGJ is priced at $0.00, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, ACGJ is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs OXIHF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, OXIHF has a market cap of 788.7K. Regarding current trading prices, ACGJ is priced at $0.00, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas OXIHF's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, ACGJ is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs LGNYZ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, LGNYZ has a market cap of 677.2K. Regarding current trading prices, ACGJ is priced at $0.00, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, ACGJ is less volatile compared to LGNYZ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs RADCQ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, ACGJ is priced at $0.00, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, ACGJ's ROE is N/A, compared to RADCQ's ROE of +0.94%. Regarding short-term risk, ACGJ is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs AEGY Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, ACGJ is priced at $0.00, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas AEGY's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to AEGY's ROE of +0.00%. Regarding short-term risk, ACGJ is less volatile compared to AEGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs MDIN Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, MDIN has a market cap of 301K. Regarding current trading prices, ACGJ is priced at $0.00, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas MDIN's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to MDIN's ROE of +0.36%. Regarding short-term risk, ACGJ is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs TSTS Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, TSTS has a market cap of 127.5K. Regarding current trading prices, ACGJ is priced at $0.00, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas TSTS's P/E ratio is -0.01. In terms of profitability, ACGJ's ROE is N/A, compared to TSTS's ROE of +2.32%. Regarding short-term risk, ACGJ is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs OMHE Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, OMHE has a market cap of 98.3K. Regarding current trading prices, ACGJ is priced at $0.00, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas OMHE's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to OMHE's ROE of +0.73%. Regarding short-term risk, ACGJ is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs LGNDZ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, LGNDZ has a market cap of 73.3K. Regarding current trading prices, ACGJ is priced at $0.00, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, ACGJ is less volatile compared to LGNDZ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs IPAH Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, IPAH has a market cap of 66.7K. Regarding current trading prices, ACGJ is priced at $0.00, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas IPAH's P/E ratio is -0.01. In terms of profitability, ACGJ's ROE is N/A, compared to IPAH's ROE of -0.82%. Regarding short-term risk, ACGJ is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs HADV Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, HADV has a market cap of 64.4K. Regarding current trading prices, ACGJ is priced at $0.00, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas HADV's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to HADV's ROE of +0.83%. Regarding short-term risk, ACGJ is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs PXYN Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, PXYN has a market cap of 63.5K. Regarding current trading prices, ACGJ is priced at $0.00, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas PXYN's P/E ratio is 0.02. In terms of profitability, ACGJ's ROE is N/A, compared to PXYN's ROE of -0.20%. Regarding short-term risk, ACGJ is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs SPPH Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SPPH has a market cap of 58.9K. Regarding current trading prices, ACGJ is priced at $0.00, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SPPH's P/E ratio is -0.07. In terms of profitability, ACGJ's ROE is N/A, compared to SPPH's ROE of -0.50%. Regarding short-term risk, ACGJ is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs IMMB Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, IMMB has a market cap of 57.5K. Regarding current trading prices, ACGJ is priced at $0.00, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas IMMB's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to IMMB's ROE of -0.09%. Regarding short-term risk, ACGJ and IMMB have similar daily volatility (0.00).
ACGJ vs RBII Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, RBII has a market cap of 49.9K. Regarding current trading prices, ACGJ is priced at $0.00, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas RBII's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to RBII's ROE of -0.04%. Regarding short-term risk, ACGJ is less volatile compared to RBII. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs LGNXZ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, LGNXZ has a market cap of 25.1K. Regarding current trading prices, ACGJ is priced at $0.00, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, ACGJ is less volatile compared to LGNXZ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs CAFS Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, CAFS has a market cap of 19.9K. Regarding current trading prices, ACGJ is priced at $0.00, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas CAFS's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to CAFS's ROE of +1.94%. Regarding short-term risk, ACGJ and CAFS have similar daily volatility (0.00).
ACGJ vs SCRCQ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SCRCQ has a market cap of 14.1K. Regarding current trading prices, ACGJ is priced at $0.00, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, ACGJ's ROE is N/A, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, ACGJ is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs IXSBF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, ACGJ is priced at $0.00, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, ACGJ's ROE is N/A, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, ACGJ is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs VIAP Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, ACGJ is priced at $0.00, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas VIAP's P/E ratio is -0.05. In terms of profitability, ACGJ's ROE is N/A, compared to VIAP's ROE of +0.65%. Regarding short-term risk, ACGJ is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs ALST Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ALST has a market cap of 8.1K. Regarding current trading prices, ACGJ is priced at $0.00, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ALST's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to ALST's ROE of +0.13%. Regarding short-term risk, ACGJ and ALST have similar daily volatility (0.00).
ACGJ vs HBOSF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, ACGJ is priced at $0.00, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, ACGJ's ROE is N/A, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, ACGJ and HBOSF have similar daily volatility (0.00).
ACGJ vs CNBI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, CNBI has a market cap of 7.6K. Regarding current trading prices, ACGJ is priced at $0.00, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas CNBI's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to CNBI's ROE of +0.17%. Regarding short-term risk, ACGJ is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs IYXI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, IYXI has a market cap of 5.3K. Regarding current trading prices, ACGJ is priced at $0.00, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas IYXI's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to IYXI's ROE of +1.71%. Regarding short-term risk, ACGJ and IYXI have similar daily volatility (0.00).
ACGJ vs ISHI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, ISHI has a market cap of 1.6K. Regarding current trading prices, ACGJ is priced at $0.00, while ISHI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas ISHI's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to ISHI's ROE of N/A. Regarding short-term risk, ACGJ is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs FSPM Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, ACGJ is priced at $0.00, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas FSPM's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to FSPM's ROE of N/A. Regarding short-term risk, ACGJ and FSPM have similar daily volatility (0.00).
ACGJ vs GRPI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, ACGJ is priced at $0.00, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas GRPI's P/E ratio is -0.02. In terms of profitability, ACGJ's ROE is N/A, compared to GRPI's ROE of +0.09%. Regarding short-term risk, ACGJ and GRPI have similar daily volatility (0.00).
ACGJ vs AXMP Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, AXMP has a market cap of 409. Regarding current trading prices, ACGJ is priced at $0.00, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas AXMP's P/E ratio is 0.00. In terms of profitability, ACGJ's ROE is N/A, compared to AXMP's ROE of N/A. Regarding short-term risk, ACGJ and AXMP have similar daily volatility (0.00).
ACGJ vs DECN Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, DECN has a market cap of 354. Regarding current trading prices, ACGJ is priced at $0.00, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas DECN's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to DECN's ROE of +0.00%. Regarding short-term risk, ACGJ and DECN have similar daily volatility (0.00).
ACGJ vs MDVLQ Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, MDVLQ has a market cap of 323. Regarding current trading prices, ACGJ is priced at $0.00, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, ACGJ is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs NEWG Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, NEWG has a market cap of 23. Regarding current trading prices, ACGJ is priced at $0.00, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas NEWG's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to NEWG's ROE of +0.40%. Regarding short-term risk, ACGJ and NEWG have similar daily volatility (0.00).
ACGJ vs SYNI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, SYNI has a market cap of 3. Regarding current trading prices, ACGJ is priced at $0.00, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas SYNI's P/E ratio is -0.00. In terms of profitability, ACGJ's ROE is N/A, compared to SYNI's ROE of N/A. Regarding short-term risk, ACGJ and SYNI have similar daily volatility (0.00).
ACGJ vs GHTI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, GHTI has a market cap of 0. Regarding current trading prices, ACGJ is priced at $0.00, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas GHTI's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to GHTI's ROE of N/A. Regarding short-term risk, ACGJ is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for ACGJ.
ACGJ vs TFSHF Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, ACGJ is priced at $0.00, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas TFSHF's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to TFSHF's ROE of N/A. Regarding short-term risk, ACGJ and TFSHF have similar daily volatility (0.00).
ACGJ vs MDSI Comparison
ACGJ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACGJ stands at 324. In comparison, MDSI has a market cap of 0. Regarding current trading prices, ACGJ is priced at $0.00, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACGJ currently has a P/E ratio of -0.00, whereas MDSI's P/E ratio is N/A. In terms of profitability, ACGJ's ROE is N/A, compared to MDSI's ROE of N/A. Regarding short-term risk, ACGJ and MDSI have similar daily volatility (0.00).